Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cardiometabolic Effects of Pecans
NCT04487808Phase 2Withdrawn
- Sponsor
- The Pennsylvania State University
- Start
- May 2021
- Primary completion
- Jul 2022
01
Overview
Phase 2, randomised, open-label trial (3 arms), sponsored by The Pennsylvania State University. Primary endpoint: Flow mediated dilation at 4 weeks. Planned start May 2021; status: withdrawn.
Beyond the preview
Go deeper on NCT04487808.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04487808.